Ligand Pharmaceuticals, Inc. (LGND)
203.68
+4.20
(+2.11%)
USD |
NASDAQ |
Jan 22, 16:00
203.68
0.00 (0.00%)
After-Hours: 17:53
Ligand Pharmaceuticals Market Cap: 4.009B for Jan. 22, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 270.89B |
| Johnson & Johnson | 526.67B |
| Elanco Animal Health, Inc. | 12.37B |
| Ionis Pharmaceuticals, Inc. | 13.26B |
| Krystal Biotech, Inc. | 8.385B |
Market Cap Related Metrics
| PE Ratio | 98.03 |
| PS Ratio | 15.96 |
| Price to Book Value | 4.219 |
| Price to Free Cash Flow | 196.21 |
| Price | 203.68 |
| Earnings Yield | 1.02% |
| Operating PE Ratio | 138.96 |
| Normalized PE Ratio | 902.86 |